April 29th 2025
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
April 28th 2025
The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.
April 24th 2025
The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled syringes and cartridges.
April 15th 2025
One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.
A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.
McKesson Jumps Into Plasma, Blood-Based Products Wholesaling
New unit will ship from La Vergne, TN specialty-care products warehouse
Armada Gathers 1,000 Attendees at its 5th Specialty Pharmacy Summit
Specialty GPO is doubling attendance year-over-year
2008 Market Summary From IMS Health: US Pharma Sales Up 1.3%, the Lowest in Decades
US total reaches $291.5 billion; dispensed prescriptions up 0.9%
Stem Cell Therapy: Business Models Begin to Take Shape
Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy
Independent Pharmacies Promote the Value of Their Patient Contact to the Pharma Industry
Although beset by less-than-friendly federal reimbursement policies, independent pharmacies are maintaining their viability for pharmaceutical delivery
Long-Term Drug Approval Trends Highlight the Industry's Productivity Dilemma
Higher complexity—and expense—are the reality for most drug research, says Tufts
Novartis Managed Care Report Finds Higher Barriers to Drug Access
Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity
Examining the ROI of personalized medicine
New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics